What is NDC 71921-105?

71921-105 is the product NDC for Tenofovir Disoproxil Fumarate, Tenofovir disoproxil fumarate 300 mg/1 tablet, coated, listed with the FDA by Florida Pharmaceutical Products, LLC.. It has 1 package NDC, shown above in 10- and 11-digit form.

Florida Pharmaceutical Products, LLC., NDC labeler code 71921. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Tenofovir Disoproxil Fumarate?

18 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Tenofovir Disoproxil Fumarate NDC 71921-105

NDC codes

FDA NDC Directory

Product NDC (as listed)71921-105Labeler and product segments. Claims need a package NDC.

Product NDC at billing width71921-0105Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
71921-105-33	7192101053371921010533	30 TABLET, COATED in 1 BOTTLE, PLASTIC (71921-105-33)Marketed from Nov 26, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Tenofovir Disoproxil Fumarate
Generic name (nonproprietary): tenofovir disoproxil fumarate
Active ingredients: Tenofovir disoproxil fumarate — 300 mg/1
Dosage form: Tablet, Coated
Route: Oral
Labeler: Florida Pharmaceutical Products, LLC.NDC labeler code 71921
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 209498
Marketing start: Nov 26, 2025
Listing expires: Dec 31, 2026
Other FDA classes: Nucleoside Reverse Transcriptase Inhibitors (Mechanism)Nucleosides (Chemical structure)
Identifiers: Product ID 71921-105_79278443-b9ee-4db6-ac15-a3d12b359eb0SPL ID 79278443-b9ee-4db6-ac15-a3d12b359eb0SPL set ID 0c7d72d6-bf80-49e0-921c-20169e87e62fRxCUI 349251UNII OTT9J7900IUPC 0371921105335
Pharmacologic class: Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471921010533 followed by a unit qualifier and the quantity

Package 71921-0105-33. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 11, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

Tenofovir disoproxil fumarate is a nucleotide analog HIV-1 reverse transcriptase inhibitor and an HBV reverse transcriptase inhibitor and is indicated: in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and pediatric patients 2 years of age and older weighing at least 35 kg. ( 1.1 ) for the treatment of chronic hepatitis B in adults and pediatric patients 2 years and older weighing at least 35 kg. ( 1.2 ) 1.1 HIV-1 Infection Tenofovir disoproxil fumarate is indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults and pediatric patients 2 years of age and older wei…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 71921-105

What is NDC 71921-105?: 71921-105 is the product NDC for Tenofovir Disoproxil Fumarate, Tenofovir disoproxil fumarate 300 mg/1 tablet, coated, listed with the FDA by Florida Pharmaceutical Products, LLC.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Tenofovir Disoproxil Fumarate.
What is the active ingredient?: Tenofovir disoproxil fumarate.
Who is the labeler?: Florida Pharmaceutical Products, LLC., NDC labeler code 71921. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Tenofovir Disoproxil Fumarate?: 18 other product NDCs are listed under this name. See all Tenofovir Disoproxil Fumarate NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Tenofovir Disoproxil Fumarate NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Tenofovir Disoproxil Fumarate	Tenofovir disoproxil fumarate 300 mg/1	Tablet, CoatedOral	Bryant Ranch Prepack	71335-3155	71335-3155-0171335-3155-02
Tenofovir Disoproxil Fumarate	Tenofovir disoproxil fumarate 300 mg/1	Tablet, Film coatedOral	PD-Rx Pharmaceuticals, Inc.	72789-361	72789-0361-07
Tenofovir Disoproxil Fumarate	Tenofovir disoproxil fumarate 300 mg/1	TabletOral	AvPAK	50268-758	50268-0758-12
Tenofovir Disoproxil Fumarate	Tenofovir disoproxil fumarate 300 mg/1	Tablet, CoatedOral	Quinn Pharmaceuticals	69076-105	69076-0105-03
Tenofovir Disoproxil Fumarate	Tenofovir disoproxil fumarate 300 mg/1	Tablet, CoatedOral	Bryant Ranch Prepack	71335-2364	71335-2364-0171335-2364-02
Tenofovir Disoproxil Fumarate	Tenofovir disoproxil fumarate 300 mg/1	Tablet, Film coatedOral	AvKARE	42291-800	42291-0800-30
Tenofovir Disoproxil Fumarate	Tenofovir disoproxil fumarate 300 mg/1	Tablet, Film coatedOral	NorthStar RxLLC	16714-820	16714-0820-01
Tenofovir Disoproxil Fumarate	Tenofovir disoproxil fumarate 300 mg/1	Tablet, Film coatedOral	A-S Medication Solutions	50090-7202	50090-7202-00
Tenofovir Disoproxil Fumaratetenofovir disoproxil fumarate tablets	Tenofovir disoproxil fumarate 300 mg/1	Tablet, Film coatedOral	Chartwell RX, LLC.	62135-466	62135-0466-30
tenofovir disoproxil fumarate	Tenofovir disoproxil fumarate 300 mg/1	Tablet, Film coatedOral	Major Pharmaceuticals	0904-6821	00904-6821-04

All 19 Tenofovir Disoproxil Fumarate NDCs

Other NDCs under ANDA 209498

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 209498
Product	Strength	Form · route	Labeler	Product NDC
Tenofovir Disoproxil Fumarate	Tenofovir disoproxil fumarate 300 mg/1	Tablet, CoatedOral	Quinn Pharmaceuticals	69076-105
Tenofovir Disoproxil Fumarate	Tenofovir disoproxil fumarate 300 mg/1	Tablet, CoatedOral	Bryant Ranch Prepack	71335-2364
Tenofovir Disoproxil Fumarate	Tenofovir disoproxil fumarate 300 mg/1	Tablet, CoatedOral	Bryant Ranch Prepack	71335-3155